Inventor
Ting AN
Inventor
CN
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides21%
G01NInvestigating or analysing materials by determining their chemical or physical properties21%
C12NMicroorganisms or enzymes7%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data4%
H04NPictorial communication, e.g. television4%
PatentTitleYear
12,063,444Digital event encoding for operating an event-based image sensor202411,834,516Tumor-specific polypeptide and use thereof202311,612,643Col14A1-derived tumor antigen polypeptide and use thereof202311,548,925CACNA1H-derived tumor antigen polypeptide and use thereof202311,213,563Polypeptide and use thereof202211,161,874Tumor-specific polypeptide and use thereof202111,142,547Polypeptide and use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to GENOIMMUNE THERAPEUTICS CO LTD (6)· patent assignee history
2021–2023Based in CN· patent location history
2024Patents assigned to PROPHESEE (1)· patent assignee history
2024Based in FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENOIMMUNE THERAPEUTICS CO LTD | 6 | 2021–2023 |
| PROPHESEE | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 6 | 2021–2023 |
| FR | 1 | 2024 |